(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-11 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 2467733
Date | Daily Closing Price | Open | High | Low | Volume |
11 Wed Dec 2024 | 47.39 | 49.24 | 49.35 | 47.08 | 0.502 times |
10 Tue Dec 2024 | 49.06 | 49.26 | 49.79 | 48.32 | 0.441 times |
09 Mon Dec 2024 | 49.07 | 48.20 | 49.27 | 47.90 | 0.241 times |
26 Tue Nov 2024 | 47.79 | 47.53 | 48.17 | 46.27 | 0.567 times |
26 Tue Nov 2024 | 47.79 | 47.53 | 48.17 | 46.27 | 0.567 times |
25 Mon Nov 2024 | 47.79 | 49.51 | 50.00 | 47.01 | 1.302 times |
22 Fri Nov 2024 | 49.00 | 48.93 | 49.57 | 46.21 | 1.844 times |
21 Thu Nov 2024 | 45.70 | 45.85 | 46.12 | 44.80 | 0.526 times |
20 Wed Nov 2024 | 45.76 | 44.57 | 46.20 | 44.10 | 0.76 times |
19 Tue Nov 2024 | 44.81 | 43.81 | 45.30 | 42.65 | 1.529 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 45.4 as stoploss in an intra day buy trade for a target of 51.78. However, stock will show a bearish move below 45.4.
Share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Target | 42.01 |
Downside Target | 45.63 |
Upside Target | 48.17 |
Upside Target | 50.00 |
Upside Target | 51.46 |
Upside Target | 55.43 |
Upside Target | 62.00 |
Upside Target | 62.13 |
Upside Target | 64.18 |
Upside Target | 65.53 |
Intraday share price targets for Halozyme Therapeutics (HALO)
Target Type | Value |
Downside Intraday Target | 46.38 |
Downside Intraday Target | 45.38 |
Upside Intraday Target | 49.09 |
Upside Intraday Target | 50.8 |
Upside Intraday Target | 48.09 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Wed Dec 2024 | 47.39 | 48.20 | 49.79 | 47.08 | 2.087 times |
26 Tue Nov 2024 | 47.79 | 47.53 | 48.17 | 46.27 | 0.304 times |
26 Tue Nov 2024 | 47.79 | 49.51 | 50.00 | 46.27 | 0.272 times |
22 Fri Nov 2024 | 49.00 | 45.66 | 49.57 | 42.01 | 1.191 times |
15 Fri Nov 2024 | 45.65 | 61.13 | 62.13 | 45.63 | 2.046 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Wed Dec 2024 | 47.39 | 48.20 | 49.79 | 47.08 | 0.061 times |
26 Tue Nov 2024 | 47.79 | 55.66 | 62.13 | 42.01 | 1.548 times |
31 Thu Oct 2024 | 50.57 | 56.97 | 62.00 | 48.84 | 1.161 times |
30 Mon Sep 2024 | 57.24 | 63.59 | 64.18 | 55.43 | 0.887 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.27 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.27 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.